3,4-dihydroxyphenylacetic acid has been researched along with toluene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agnati, LF; Andbjer, B; Cintra, A; Finnman, UB; Fuxe, K; Hagman, M; Höglund, G | 1 |
| Agnati, LF; Aguirre, JA; Andbjer, B; Cintra, A; Finnman, UB; Fuxe, K; Hagman, M; Höglund, C; Möller, A | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and toluene
| Article | Year |
|---|---|
Subacute toluene exposure increases DA dysfunction in the 6-OH dopamine lesioned nigrostriatal dopaminergic system of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Drug Administration Schedule; Drug Synergism; Male; Neurotoxins; Norepinephrine; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra; Toluene | 1996 |
Subchronic toluene exposure in low concentrations produces signs of reduced dysfunction in the 6-hydroxydopamine lesioned nigrostriatal dopaminergic system of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Behavior, Animal; Denervation; Dopamine; Injections, Intraventricular; Male; Motor Activity; Neostriatum; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Substantia Nigra; Toluene; Tyrosine 3-Monooxygenase | 1999 |